成分词典

SOLUM DIATOMEAE

Silicon dioxide is a silicon oxide made up of linear triatomic molecules in which a silicon atom is covalently bonded to two oxygens.

产品中实际含有多少

暂无产品标示该成分含量。

含该成分的产品中，3,852 款将其列在 1% 线之前，464 款列在之后（通常不超过 1%）。

含有此成分的产品

已确认 4,243 款中的 12 款 · 按含量充足程度排序 · 查看全部 4,243 款

定义

Silicon dioxide is a silicon oxide made up of linear triatomic molecules in which a silicon atom is covalently bonded to two oxygens.

来源: PubChem

Silicon dioxide

化妆品中的作用

使透明剂型变浑浊OPACIFYING吸收水分或油脂ABSORBENT物理摩擦清洁ABRASIVE防止粉体结块ANTICAKING

安全与法规参考

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息（环境公团）

详细资料——标示名称、识别编号、物性、试验记录、文献

别名和识别信息

SOLUM DIATOMEAEINCISilica同义名

CAS No.化学物质登记号: 7631-86-9
EC No.欧盟化学品目录编号: 231-545-4
DTXSID美国EPA化学品编号: DTXSID1029677
DTXCID美国EPA化合物编号: DTXCID009677

IUPAC: Silanedione
分子式: O2Si
分子量: 60.083 g/mol

实测物性

性状: Transparent to gray, odorless powder. Irritating to the skin and eyes on contact. Inhalation will cause irritation in the respiratory tract. [Note: Amorphous silica is the non-crystalline form of SiO2.] · Dry Powder, Other Solid, Large Crystals, CBI
气味: Odorless · 无臭
沸点: 4046 °F at 760 mmHg (NIOSH, 2024) · 4046 °F
熔点: 3110 °F (NIOSH, 2024) · 3110 °F
溶解性: Insoluble (NIOSH, 2024) · The solubility of the various phases of silicas is very complex and depends upon several factors. Solubility increases with temperature and pH and is affected by the presence of trace metals. Particle size influences the rate of solubility. /Silica/
pH: 3.5-4.4
熔点/凝固点: &amp, gt, 1600 ℃
初沸点和沸程: &amp, gt, 2230 ℃
比重: 2.19-2.66
分子量: 60.09

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

来源: PubChem · 韩国安全保健公团安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 656 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

Processing aids not otherwise specified100
Filler99
Anti-caking agent54
Pigment38
Degradant/impurity (EPA)32
No specific technical function31
Viscosity modifier29
Thickening agent26

其余用途 54 项

Defoamer17
Absorbent16
Abrasive15
Binder15
Monomers14
Surface modifier11
Adsorbent10
Conductive agent9
Anti-adhesive/cohesive9
Flow promoter9
Opacifer9
Adhesion/cohesion promoter8
Dispersing agent7
Crystal growth modifiers (nucleating agents)6
Wetting agent (non-aqueous)6
Dye5
Catalyst5
Lubricating agent4
Emulsifier4
Antioxidant4
Drier4
Intermediate4
Hardener4
Soil amendments3
Fragrance3
Dehydrating agent (desiccant)3
Surfactant (surface active agent)2
Photosensitive agent2
Anti-slip agent2
Propellants, non-motive (blowing agents)2
Fixing agent (mordant)2
Insulators2
Plating agent2
Plasticizer2
Chemical reaction regulator2
Semiconductor and photovoltaic agent2
Softener and conditioner2
Fuel2
Stabilizing agent2
Anti-static agent2
Solids separation (precipitating) agent, not other2
Flavouring and nutrient1
Corrosion inhibitor1
pH regulating agent1
Density modifier1
Ion exchange agent1
Bleaching agent1
Etching agent1
Flux agent1
Dusting agent1
Swelling agent1
Waterproofing agent1
Pharmaceutical disintegrant (EPA)1
Humectant1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 7 项、眼部试验 9 项。

归类为低10 项

试验结论基本一致（100%）。这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 16 项试验

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: National standard protocol (No. IPC/05-92) corresponding to US EPA according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EPA OPPTS 870.2500 (Acute Dermal Irritation) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to other guideline: Patch-Test; Hazardous Substances, Part 191, Section 11, FDA, Washington, 1965 according to
Classification not possible
Skin Sensitization · Screening
Not classified
Skin Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Act (1973) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Draize-Test; Hazardous Substances, Part 191, Section 12, Federal Register, Vol. 37, No. 83, FDA, Washington 1972 according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EPA OPPTS 870.2400 (Acute Eye Irritation) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · no guideline available other guideline: Draize-Test equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Draize-Test; Hazardous Substances, Part 191, Section 12, Federal Register, Vol. 37, No. 83, FDA, Washington according to
Category 2
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to